Expand / Collapse search
Watch TV
☰

Quotes displayed in real-time or delayed by at least 15 minutes. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions.  Legal Statement.

This material may not be published, broadcast, rewritten, or redistributed. ©2024 FOX News Network, LLC. All rights reserved. FAQ - New Privacy Policy

eastman chemical co. - EMN

EMN

Close Chg Chg %
103.57 2.03 1.96%

Closed Market

105.60

+2.03 (1.96%)

Volume: 1.01M

Last Updated:

Nov 22, 2024, 3:59 PM EDT

Trade Now

Company Overview: eastman chemical co. - EMN

EMN Key Data

Open

$103.81

 Day Range

103.70 - 105.83

52 Week Range

80.71 - 114.50

 Market Cap

$12.01B

Shares Outstanding

115.91M

 Public Float

115.18M

Beta

1.46

 Rev. Per Employee

N/A

P/E Ratio

13.86

 EPS

$7.54

Yield

312.74%

 Dividend

$0.81

EX-DIVIDEND DATE

Sep 16, 2024

 SHORT INTEREST

N/A

AVERAGE VOLUME

1.08M

  

EMN Performance

1 Week
 
 3.92%
 
1 Month
 
 0.15%
 
3 Months
 
 4.75%
 
1 Year
 
 28.94%
 
5 Years
 
 36.09%
 

EMN Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 22
Full Ratings ➔

About eastman chemical co. - EMN

Eastman Chemical Co. engages in the provision of specialty chemicals. It operates through the following segments: Advanced Material (AM), Additives and Functional Products (AFP), Chemical Intermediates (CI), and Fibers. The AM segment produces and markets its polymers, films, and plastics with differentiated performance properties for value-added end uses in transportation, consumables, building and construction, durable goods, and health and wellness markets. The AFP segment includes chemicals for products in the transportation, consumables, building and construction, animal nutrition, crop protection, energy, personal and home care, and other markets. The CI segment consists of large scale and vertical integration from the cellulose and acetyl, olefins, and alkylamines streams to support operating segments with advantaged cost positions. The Fibers segment offers cellulose acetate tow for use in filtration media, primarily cigarette filters. The company was founded by George Eastman in 1920 and is headquartered in Kingsport, TN.

EMN At a Glance

Eastman Chemical Co.
200 South Wilcox Drive
Kingsport, Tennessee 37660-5280
Phone 1-423-229-2000 Revenue 9.20B
Industry Chemicals: Specialty Net Income 894.00M
Sector Process Industries Employees 14,000
Fiscal Year-end 12 / 2024
View SEC Filings

EMN Valuation

P/E Current 13.86
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) 11.996
Price to Sales Ratio 1.166
Price to Book Ratio 1.93
Price to Cash Flow Ratio 7.805
Enterprise Value to EBITDA 9.577
Enterprise Value to Sales 1.66
Total Debt to Enterprise Value 0.329

EMN Efficiency

Revenue/Employee 657,000.00
Income Per Employee 63,857.143
Receivables Turnover 7.971
Total Asset Turnover 0.628

EMN Liquidity

Current Ratio 1.351
Quick Ratio 0.698
Cash Ratio 0.213

EMN Profitability

Gross Margin 22.418
Operating Margin 11.916
Pretax Margin 11.818
Net Margin 9.72
Return on Assets 6.102
Return on Equity 16.85
Return on Total Capital 8.534
Return on Invested Capital 9.307

EMN Capital Structure

Total Debt to Total Equity 91.938
Total Debt to Total Capital 47.90
Total Debt to Total Assets 34.292
Long-Term Debt to Equity 81.074
Long-Term Debt to Total Capital 42.239
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Eastman Chemical Co. - EMN

Collapse All in section
All values USD millions. 2020 2021 2022 2023 5-year trend
Sales/Revenue
8.46B 10.48B 10.54B 9.20B
Sales Growth
-8.47% +23.85% +0.50% -12.69%
Cost of Goods Sold (COGS) incl D&A
6.46B 7.96B 8.48B 7.14B
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
574.00M 538.00M 477.00M 498.00M
Depreciation
446.00M 430.00M 390.00M 412.00M
Amortization of Intangibles
128.00M 108.00M 87.00M 86.00M
COGS Growth
-7.72% +23.32% +6.45% -15.84%
Gross Income
2.00B 2.52B 2.06B 2.06B
Gross Income Growth
-10.81% +25.59% -18.35% +0.29%
Gross Profit Margin
+23.69% +24.02% +19.52% +22.42%
2020 2021 2022 2023 5-year trend
SG&A Expense
880.00M 1.05B 972.00M 966.00M
Research & Development
226.00M 254.00M 264.00M 239.00M
Other SG&A
654.00M 795.00M 708.00M 727.00M
SGA Growth
-4.86% +19.20% -7.34% -0.62%
Other Operating Expense
- - - -
-
Unusual Expense
237.00M 52.00M 81.00M 65.00M
EBIT after Unusual Expense
888.00M 1.42B 1.00B 1.03B
Non Operating Income/Expense
(153.00M) (143.00M) 156.00M 278.00M
Non-Operating Interest Income
4.00M 3.00M 6.00M 10.00M
Equity in Earnings of Affiliates
15.00M 16.00M 19.00M 10.00M
Interest Expense
205.00M 192.00M 182.00M 222.00M
Interest Expense Growth
-4.65% -6.34% -5.21% +21.98%
Gross Interest Expense
209.00M 197.00M 191.00M 240.00M
Interest Capitalized
4.00M 5.00M 9.00M 18.00M
Pretax Income
530.00M 1.08B 977.00M 1.09B
Pretax Income Growth
-41.24% +104.15% -9.70% +11.26%
Pretax Margin
+6.26% +10.32% +9.27% +11.82%
Income Tax
41.00M 215.00M 181.00M 191.00M
Income Tax - Current - Domestic
75.00M 138.00M 212.00M 140.00M
Income Tax - Current - Foreign
77.00M 115.00M 105.00M 153.00M
Income Tax - Deferred - Domestic
(97.00M) 4.00M (126.00M) (67.00M)
Income Tax - Deferred - Foreign
(14.00M) (42.00M) (10.00M) (35.00M)
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
15.00M 16.00M 19.00M 10.00M
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
489.00M 867.00M 796.00M 896.00M
Minority Interest Expense
11.00M 10.00M 3.00M 2.00M
Net Income
478.00M 857.00M 793.00M 894.00M
Net Income Growth
-37.02% +79.29% -7.47% +12.74%
Net Margin Growth
+5.65% +8.18% +7.53% +9.72%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
478.00M 857.00M 793.00M 894.00M
Preferred Dividends
- - - -
-
Net Income Available to Common
478.00M 857.00M 793.00M 894.00M
EPS (Basic)
3.5277 6.3528 6.421 7.5379
EPS (Basic) Growth
-36.14% +80.08% +1.07% +17.39%
Basic Shares Outstanding
135.50M 134.90M 123.50M 118.60M
EPS (Diluted)
3.5018 6.2509 6.3491 7.4874
EPS (Diluted) Growth
-36.10% +78.51% +1.57% +17.93%
Diluted Shares Outstanding
136.50M 137.10M 124.90M 119.40M
EBITDA
1.70B 2.01B 1.56B 1.59B
EBITDA Growth
-12.11% +18.13% -22.22% +2.11%
EBITDA Margin
+20.07% +19.15% +14.82% +17.33%

Snapshot

Average Recommendation OVERWEIGHT Average Target Price 114.684
Number of Ratings 22 Current Quarters Estimate 1.609
FY Report Date 12 / 2024 Current Year's Estimate 7.636
Last Quarter’s Earnings 2.26 Median PE on CY Estimate N/A
Year Ago Earnings 6.40 Next Fiscal Year Estimate 8.695
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 18 9 18 19
Mean Estimate 1.61 1.95 7.64 8.69
High Estimates 1.68 2.07 7.72 9.70
Low Estimate 1.53 1.75 7.55 8.30
Coefficient of Variance 2.41 5.60 0.58 3.78

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 8 8 9
OVERWEIGHT 0 1 1
HOLD 14 13 12
UNDERWEIGHT 0 0 0
SELL 0 0 0
MEAN Overweight Overweight Overweight

Insider Actions for Eastman Chemical Co. - EMN

Date Name Shares Transaction Value
Nov 8, 2024 Christopher M. Killian SVP & CTO 12,366 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $105 per share 1,298,430.00
Oct 10, 2024 Eric L. Butler Director 1,762 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Oct 10, 2024 James J. O'Brien Director 15,640 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Oct 10, 2024 Linnie M. Haynesworth Director 2,577 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Oct 10, 2024 Kim Ann Mink Director 11,898 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Oct 10, 2024 Humberto P. Alfonso Director 46,416 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Oct 10, 2024 Humberto P. Alfonso Director 46,139 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Oct 10, 2024 Julie Fasone Holder Director 12,768 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Oct 10, 2024 Renée J. Hornbaker Director 46,331 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Oct 10, 2024 David Wayne Raisbeck Director 51,654 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Oct 10, 2024 Donald W. Slager Director 339 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Oct 10, 2024 Brett D. Begemann Director 48,248 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Oct 10, 2024 Brett D. Begemann Director 47,971 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Oct 4, 2024 Bosede Ikeolu Gbadegesin SVP, CLO & Corporate Secretary 16,994 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Jun 5, 2024 Adrian James Holt SVP, Chf HR Ofcr N/A Open market or private sale of non-derivative or derivative security Non-derivative transaction at $99.22 per share 0.00
Jun 5, 2024 Adrian James Holt SVP, Chf HR Ofcr 3,950 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Jun 5, 2024 Adrian James Holt SVP, Chf HR Ofcr 1,975 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $77.75 per share 153,556.25
May 17, 2024 Brad A. Lich EVP & CCO N/A Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
May 17, 2024 Brad A. Lich EVP & CCO 68,793 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $100.51 per share 6,914,384.43
May 17, 2024 Brad A. Lich EVP & CCO 91,821 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $74.46 per share 6,836,991.66

Eastman Chemical Co. in the News